logo

For the Inventor, By the Inventor

Indianapolis, IN, United States of America

Kenneth Allen Savin

USPTO Granted Patents = 22 


Average Co-Inventor Count = 8.4

ph-index = 10

Forward Citations = 313(Granted Patents)


Location History:

  • New York, NY (US) (2001 - 2010)
  • Indianapolis, IN (US) (2003 - 2013)

Company Filing History:

goldMedal17 out of 512 
 
Sloan-kettering Institute for Cancer Research
 patents
silverMedal5 out of 4,446 
 
Eli Lilly and Company
 patents

Years Active: 2001-2013

Loading Chart...
Loading Chart...
22 patents (USPTO):Explore Patents
1. 8481575 - Synthesis of epothilones, intermediates thereto, analogues and uses thereof (2013-07-09),
2. 7902356 - Thiazolopyridinone derivates as MCH receptor antagonists (2011-03-08),
3. RE41990 - Synthesis of epothilones, intermediates thereto, analogues and uses thereof (2010-12-06),
4. 7838543 - MCH receptor antagonists (2010-11-23),
5. 7750164 - Synthesis of epothilones, intermediates thereto, analogues and uses thereof (2010-07-06),
6. 7320994 - Triazole derivatives as tachykinin receptor antagonists (2008-01-22),
7. 7229987 - Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes (2007-06-12),
8. 7179804 - Tachykinin receptor antagonists (2007-02-20),
9. 6972335 - Synthesis of epothilones, intermediates thereto, analogues and uses thereof (2005-12-06),
10. 6965034 - Synthesis of epothilones, intermediates thereto and analogues thereof (2005-11-15),
11. 6849651 - Synthesis of epothilones, intermediates thereto, analogues and uses thereof (2005-02-01),
12. 6828340 - Synthesis of epothilones, intermediates thereto, analogues and uses thereof (2004-12-07),
13. 6723854 - Synthesis of epothilones, intermediates thereto, analogues and uses thereof (2004-04-20),
14. 6656961 - Synthesis of epothilones, intermediates thereto, analogues and uses thereof (2003-12-02),
15. 6603023 - Synthesis of epothilones, intermediates thereto and analogues thereof (2003-08-05),

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I'd be happy to help you with the article about inventor Kenneth Allen Savin.

Title: The Innovative Journey of Kenneth Allen Savin

Introduction:

Kenneth Allen Savin, a prolific inventor based in Indianapolis, IN (US), has made significant contributions in the field of pharmaceuticals with an impressive portfolio of 22 patents.

Latest Patents:

Savin's latest patents showcase his expertise in the pharmaceutical industry. One notable invention is the synthesis of epothilones, analogues, and their uses in treating cancer, including multidrug-resistant phenotypes. Another groundbreaking patent is for thiazolopyridinone derivatives as MCH receptor antagonists, aimed at combating obesity and related diseases.

Career Highlights:

Throughout his career, Savin has worked at renowned institutions such as the Sloan-Kettering Institute for Cancer Research and the esteemed Eli Lilly and Company. His innovative research has paved the way for advancements in cancer treatment and obesity management.

Collaborations:

Savin has collaborated with esteemed professionals in the field, including Samuel J Danishefsky and Peter Bertinato. These partnerships have led to groundbreaking discoveries and innovative solutions in the pharmaceutical industry.

Conclusion:

In conclusion, Kenneth Allen Savin's remarkable journey as an inventor underscores his commitment to pushing the boundaries of innovation in pharmaceuticals. His pioneering work continues to make a significant impact on the field, offering new hope in the fight against cancer and obesity-related diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…